Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT — Stella

View on ClinicalTrials.gov

Recruiting

Back to Microtia trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Phase

Safety & dosing

Sponsor

Vanderbilt University Medical Center

Collaborators

University of Louisville, Boston University

Enrollment target

~250 participants

Started

September 2023

Primary completion

August 2026

Age range

18 Years – 89 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.